+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acorda Therapeutics Inc - logo

Acorda Therapeutics is a biopharmaceutical company that identifies, develops, and commercializes novel therapies for neurological disorders in the United States. It specializes in drugs that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Its best known products are Zanaflex, Ampyra and Qutenza. Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, New York.

From
From
From
From
Spinal Cord Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Multiple Sclerosis Drugs Market Report 2026 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Intranasal Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Intranasal Drug Delivery - Global Strategic Business Report

  • Report
  • April 2026
  • 320 Pages
  • Global
From
From
From
Spinal Cord Injury Market Report and Forecast 2024-2032 - Product Thumbnail Image

Spinal Cord Injury Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 1200 Pages
  • Global
From
Loading Indicator